{"schema_version":"secwatch.filing_event.v1","accession":"0001279569-26-000827","form_type":"8-K","ticker":"GRUSF","cik":"0001463000","company_name":"Grown Rogue International Inc.","filed_at":"2026-08-25T19:50:50+00:00","discovered_at":"2026-08-25T19:52:00.449561+00:00","generated_at":"2026-08-25T19:52:18.661019+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.78,"calibrated_materiality_score":0.78,"confidence":"high","headline":"Grown Rogue enters NY via JV, $15M financing commitment, plans PharmaCann NY acquisition","bullets":["Grown Rogue New York JV: capital partner invests $10M for 49% preferred equity; Grown Rogue holds 51%.","Planned purchase price ~$4.5M ($3M at regulatory approval); plus $5M drawable term loan at 15%, $9M secured loan to PCNY.","Targets: 4 Verilife dispensaries (avg $1.7-2.0M monthly sales) and Hamptonburgh facility with 24,000 sq ft indoor + 16,000 sq ft greenhouse canopy.","Preferred equity convertible to ~18.2M SVS (~7% dilution) at $0.55-0.76/share; commitment fee 300K shares + 0.901 warrants per $1 drawn.","Expects NY operations cash-flow positive within 9 months, ~$600K monthly after-tax CF within 18 months; ~$20M annual cost reductions."],"urls":{"canonical":"https://secwatch.observer/filing/0001279569-26-000827","json":"https://secwatch.observer/filing/0001279569-26-000827.json","markdown":"https://secwatch.observer/filing/0001279569-26-000827.md","text":"https://secwatch.observer/filing/0001279569-26-000827.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1463000/000127956926000827/0001279569-26-000827-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1463000/000127956926000827/grownrogue8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-25T19:52:18.661019+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}